Leanne R. Larson has been appointed vice president of Evidence Development at PAREXEL Consulting. Ms. Larson has expertise in strategy, design, implementation, and analysis of patient registries and outcomes research programs and will work to support clients with the needs of payors, regulators, physicians, and patients when making treatment decisions.
 
Ms. Larson has more than 25 years of experience in healthcare, with extensive work in pharmaceutical product development and marketing, and in healthcare technology and operational consulting. Prior to joining the company, Ms. Larson served more than 15 years in senior and strategic roles within CROs. She has also held positions in Ernst & Young’s Life Sciences and Pharmaceuticals consulting practice, as well as Merck’s Health Sciences-Digestive Disease group.
 
“Leanne Larson is a great addition to PAREXEL. Bringing on board an industry leader of her caliber further strengthens our recognized team of experts,” said Ron Kraus, corporate vice president and worldwide head of PAREXEL Consulting and Medical Communications Services. “We eagerly look forward to applying her deep knowledge and experience to support our clients in successfully commercializing their products.”